Patents by Inventor Shriprakash Dhar Dwivedi

Shriprakash Dhar Dwivedi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES
    Publication number: 20190389797
    Abstract: The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.
    Type: Application
    Filed: August 28, 2019
    Publication date: December 26, 2019
    Inventors: Shriprakash Dhar Dwivedi, Ramesh Chandra Singh, Rajendra Gokalbhai Chavda, Jagdish Maganlal Patel, Daya Ram Pal, Pranav Jitendra Gangwar, Vikas Patel, Vishwadeepak Rama Pati Tripathi
  • Process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
    Patent number: 10435363
    Abstract: The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: October 8, 2019
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Ramesh Chandra Singh, Rajendra Gokalbhai Chavda, Jagdish Maganlal Patel, Daya Ram Pal, Pranav Jitendra Gangwar, Vikas Patel, Vishwadeepak Rama Pati Tripathi
  • STABLE CRYSTALLINE FORM OF REGADENOSON
    Publication number: 20180208622
    Abstract: The present invention provides crystalline Form S of regadenoson which is substantially free of residual organic solvent and having an X-ray powder diffraction pattern comprising characteristic peak at 10.3, 10.8, 19.0, 21.6 and 25.5±0.2 degrees 2?.
    Type: Application
    Filed: September 10, 2016
    Publication date: July 26, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rajamannar THENNATI, Shriprakash Dhar DWIVEDI, Arunkumar Gulabsingh YADAV, Nischalkumar Vinodbhai PATEL, Sunil Rajaram KARANKE
  • COMPOSITION OF IRON SUCROSE AND PROCESS FOR ITS PREPARATION
    Publication number: 20180147238
    Abstract: The present invention relates to composition of iron sucrose and process for its preparation. The present invention also related to a process for the preparation of iron sucrose suitable for the iron sucrose composition.
    Type: Application
    Filed: May 27, 2016
    Publication date: May 31, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Rajamannar THENNATI, Shriprakash Dhar DWIVEDI, V S N Murty KADIYALA, V, Kanaksinh Jesingbhai JADAV, Bharat Avcharbhai KAILA, Keyur Shashikant THAKER, Binaka Rahul DOLE
  • Amorphous form of linagliptin and process for preparation thereof
    Patent number: 9879011
    Abstract: The present invention relates to an amorphous form of linagliptin and processes for the preparation thereof. The invention also relates to a pharmaceutical composition comprising a therapeutically effective amount of an amorphous form of linagliptin and use of the composition for treatment of diabetes especially type-I or type-II, prediabetes or reduction of glucose tolerance.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: January 30, 2018
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Ashok Prasad, Kuldeep Natwarlal Jain, Kumar Kamlesh Singh, Jitendra Maganbhai Gajera
  • Polymorphic forms of ivabradine hydrochloride
    Patent number: 9840469
    Abstract: Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: December 12, 2017
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Ashok Prasad, Mukul Hariprasad Sharma, Piyush Rajendra Sharma, Jayprakash Ajitsingh Parihar
  • POLYMORPHIC FORMS OF IVABRADINE HYDROCHLORIDE
    Publication number: 20170217898
    Abstract: Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.
    Type: Application
    Filed: April 12, 2017
    Publication date: August 3, 2017
    Inventors: Shriprakash Dhar DWIVEDI, Ashok PRASAD, Mukul Hariprasad SHARMA, Piyush Rajendra SHARMA, Jayprakash Ajitsingh PARIHAR
  • Processes for the preparation of lorcaserin
    Patent number: 9714225
    Abstract: The present invention relates to stable crystalline Form I of lorcaserin hydrochloride of Formula (IA) and processes for its preparation. The invention also relates to processes for the preparation of lorcaserin and pharmaceutically acceptable salts, solvates and hydrates thereof.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: July 25, 2017
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Jayprakash Ajitsingh Parihar, Alpeshkumar Pravinchandra Shah, Samir Rameshbhai Gajjar, Brij Khera
  • PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES
    Publication number: 20170144968
    Abstract: The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.
    Type: Application
    Filed: December 1, 2016
    Publication date: May 25, 2017
    Inventors: Shriprakash Dhar Dwivedi, Ramesh Chandra Singh, Rajendra Gokalbhai Chavda, Jagdish Maganlal Patel, Daya Ram Pal, Pranav Jitendra Gangwar, Vikas Patel, Vishwadeepak Rama Pati Tripathi
  • Polymorphic forms of ivabradine hydrochloride
    Patent number: 9650344
    Abstract: Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: May 16, 2017
    Assignee: CADILA HEALTHCARE LIMITED
    Inventors: Shriprakash Dhar Dwivedi, Ashok Prasad, Mukul Hariprasad Sharma, Piyush Rajendra Sharma, Jayprakash Ajitsingh Parihar
  • POLYMORPHIC FORMS OF IVABRADINE HYDROCHLORIDE
    Publication number: 20160318873
    Abstract: Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.
    Type: Application
    Filed: May 31, 2016
    Publication date: November 3, 2016
    Inventors: Shriprakash Dhar DWIVEDI, Ashok PRASAD, Mukul Hariprasad SHARMA, Piyush Rajendra SHARMA, Jayprakash Ajitsingh PARIHAR
  • PROCESSES FOR THE PREPARATION OF LORCASERIN
    Publication number: 20160280658
    Abstract: The present invention relates to stable crystalline Form A of lorcaserin hydrochloride of Formula (IA) and processes for its preparation. The invention also relates to processes for the preparation of lorcaserin and pharmaceutically acceptable salts, solvates and hydrates thereof.
    Type: Application
    Filed: November 13, 2014
    Publication date: September 29, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Shriprakash Dhar DWIVEDI,, Jayprakash Ajitsingh PARIHAR, Alpeshkumar Pravinchandra SHAH, Samir Rameshbhai GAJJAR, Brij KHERA
  • Process for the preparation of amorphous imatinib mesylate
    Patent number: 9439903
    Abstract: The field of the invention relates to a process for the preparation of amorphous imatinib mesylate. In particular, the invention relates to a process for the preparation of stable amorphous imatinib mesylate. More particularly, the invention relates to pharmaceutical compositions that includes the stable amorphous imatinib messylate together along with its excipients.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: September 13, 2016
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Kumar Kamlesh Singh, Ganpant Dan Shimbu Charan, Chetan Jayantibhai Vasava
  • Polymorphic forms of ivabradine hydrochloride
    Patent number: 9382209
    Abstract: Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: July 5, 2016
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Ashok Prasad, Mukul Hariprasad Sharma, Piyush Rajendra Sharma, Jayprakash Ajitsingh Parihar
  • AN IMPROVED PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF
    Publication number: 20160113912
    Abstract: The present invention relates to an improved process for the preparation of apixaban and intermediates thereof. In particular, the invention relates to an improved process for the preparation of an amorphous form of apixaban. The invention also relates to a pharmaceutical composition comprising an amorphous form of apixaban for oral administration as an antithrombotic agent.
    Type: Application
    Filed: June 17, 2014
    Publication date: April 28, 2016
    Inventors: Shriprakash Dhar DWIVEDI, Kumar Kamlesh SINGH, Nitin TANDON, Digambar WARE
  • A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES
    Publication number: 20160107989
    Abstract: The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.
    Type: Application
    Filed: May 30, 2014
    Publication date: April 21, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Shriprakash Dhar DWIVEDI, Ramesh Chandra SINGH, Rajendra Gokalbhai CHAVDA, Jagdish Maganlal PATEL, Daya Ram PAL, Jigar Mukundhai RAVAL, Mukul Hariprasad SHARMA, Pranav Jitendra GANGWAR, Sachin Ashokrao PATIL, Vikas PATEL, Vishwadeepak Rama Patil TRIPATHI
  • AMORPHOUS FORM OF CANAGLIFLOZIN AND PROCESS FOR PREPARING THEREOF
    Publication number: 20160083374
    Abstract: The present invention provides invention relates to stable amorphous form of Canagliflozin. The invention also provides the processes for the preparation of an amorphous form of Canagliflozin; and pharmaceutical compositions comprising therapeutically effective amount of an amorphous form of Canagliflozin, use of said composition for treatment of diabetes, obesity and diabetic complications, especially in type-2 diabetes.
    Type: Application
    Filed: May 30, 2014
    Publication date: March 24, 2016
    Inventors: Shriprakash Dhar DWIVEDI, Brij KHERA, Jayprakash Ajitsingh PARIHAR, Jagdish Maganlal PATEL
  • Process for preparation of amorphous form of dasatinib
    Patent number: 9249134
    Abstract: A stable amorphous form of dasatinib of Formula (I) wherein amorphous dasatinib after exposure to a relative humidity of 75% at 40 ° C. or 60% at 25 ° C. for a period of at least three months doesn't change to crystalline form and a process for the preparation of the amorphous form of dasatinib of Formula (I).
    Type: Grant
    Filed: March 24, 2014
    Date of Patent: February 2, 2016
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Kumar Kamlesh Singh, Nikhil Amar Singh, Amol Kashinath Patil
  • POLYMORPHIC FORMS OF IVABRADINE HYDROCHLORIDE
    Publication number: 20160024015
    Abstract: Stable crystalline Form II and stable crystalline Form III of ivabradine hydrochloride and processes for their preparation are disclosed.
    Type: Application
    Filed: August 4, 2015
    Publication date: January 28, 2016
    Inventors: Shriprakash Dhar DWIVEDI, Ashok Prasad, Mukul Hariprasad Sharma, Piyush Rajendra Sharma, Jayprakash Ajitsingh Parihar
  • Process for the preparation of dabigatran etexilate mesylate and polymorphs of intermediates thereof
    Patent number: 9212166
    Abstract: The present invention provides crystalline form of intermediates of Formula 2A, The present invention also provides process for the preparation of dabigatran etexilate mesylate; polymorph of intermediates thereof; particularly processes for the preparation of crystalline form of intermediates. The present invention also relates to the use of crystalline intermediates for the preparation of dabigatran etexilate mesylate.
    Type: Grant
    Filed: January 21, 2013
    Date of Patent: December 15, 2015
    Assignee: Cadila Healthcare Limited
    Inventors: Shriprakash Dhar Dwivedi, Ramesh Chandra Singh, Jigar Mukundbhai Raval